Hvað þýðir "Hreinsa"?
Dýrið ber ekki stökkbreytinguna. Það mun ekki þróa sjúkdóminn og mun ekki gefa það áfram.
Discover the importance of the DNA test for Bernard-Soulier Syndrome (BSS-C) in dogs, a rare genetic disorder affecting platelet function and blood clotting. Early detection through this specialized DNA test helps breeders and veterinarians identify carriers and affected dogs, preventing the spread of BSS-C in breeding lines. By understanding your dog's genetic status, you can make informed decisions to ensure healthier litters and improve overall canine health. Our accurate and reliable Bernard-Soulier Syndrome DNA test offers peace of mind for responsible dog owners. Protect your dog's future with advanced genetic screening today. Stay proactive in managing hereditary conditions with our expert testing services.
Bernard-Soulier Syndrome (BSS-C) in dogs is a rare inherited bleeding disorder caused by a genetic mutation affecting platelet function. DNA testing can identify carriers and affected dogs by detecting mutations in the GP1b gene complex. Early diagnosis through genetic screening helps breeders avoid producing affected puppies. This test is crucial for managing the health of at-risk breeds. Understanding BSS-C at the DNA level supports better treatment and prevention strategies.
Þetta DNA próf er innifalið frá pakkanum okkar Basic — og er líka hluti af pökkunum Basic, Standard, Advanced, Complete.
Skoða DNA prófunarpakka →Bernard-Soulier Syndrome (BSS-C) is a rare genetic disorder that affects blood clotting in dogs. This condition is characterized by a deficiency in the glycoprotein complex known as GPIb-IX-V, which plays a crucial role in platelet function and adhesion. As a result, dogs with BSS-C experience abnormal bleeding due to their platelets' inability to effectively bind to blood vessel walls, leading to a compromised hemostatic response.
BSS-C is inherited in an autosomal recessive manner, meaning that both copies of the gene involved must be mutated for the disease to manifest. The specific genetic mutations associated with BSS-C can be identified through DNA testing, allowing for the detection of carriers and affected individuals. Understanding the genetic basis of this condition is essential for breeding programs aimed at reducing the prevalence of BSS-C in canine populations.
Dogs affected by BSS-C may display various clinical signs that are primarily related to bleeding disorders. Common symptoms include prolonged bleeding from cuts or surgical sites, spontaneous nosebleeds, and the presence of bruises or petechiae (small red or purple spots on the skin). In more severe cases, internal bleeding can occur, which may lead to serious health complications. Early recognition and management of these symptoms are crucial for the welfare of affected dogs.
Diagnosis of Bernard-Soulier Syndrome typically involves a combination of clinical evaluation and laboratory testing. A veterinarian may observe the clinical signs and recommend blood tests to assess platelet function and count. Furthermore, DNA testing can confirm the diagnosis by identifying mutations in the genes associated with the syndrome. This comprehensive approach ensures accurate identification of the condition and aids in appropriate management strategies.
While there is no cure for Bernard-Soulier Syndrome, management strategies can help mitigate the risks associated with the condition. Supportive care may include avoiding situations that could lead to injury or bleeding. In cases of significant bleeding, veterinary intervention may be necessary, which can include blood transfusions or other therapeutic measures to stabilize the dog’s condition. Regular veterinary check-ups and monitoring are essential for managing the health of affected dogs.
Bernard-Soulier Syndrome is a significant genetic disorder that affects the hemostatic function in dogs, leading to a predisposition to bleeding. Through DNA testing, early diagnosis and management can be achieved, improving the quality of life for affected individuals. Awareness and understanding of this condition are vital for dog owners, breeders, and veterinarians alike.
Dýrið ber ekki stökkbreytinguna. Það mun ekki þróa sjúkdóminn og mun ekki gefa það áfram.
Nei. Dýrið er almennt heilbrigt en getur sent stökkbreytinguna til þess afkvæmi.
Það ber tvö stökkbreytt eintök. Búist er við klínískum einkennum eftir því sjúkdómnum. Það ætti ekki að rækta það.
Sumir sjúkdómar eru kyntengdir, þannig að tjáning þeirra er mismunandi eftir því kynlíf dýra.
This DNA test detects the mutation associated with Bernard-Soulier Syndrome (BSS-C) in order to identify clear, carrier, or at-risk animals.
DNA próf hjálpar ræktendum að skipuleggja öruggari pörun og draga úr hættu á að stökkbreytingin berist til afkvæma.
Erfðastillingin sem tilkynnt er um fyrir þetta próf er Autosomal Recessive.
This test analyses the mutation GP9 c.127_*2052del.
Ekki endilega. Túlkun fer eftir erfðamynstri og arfgerðinni sem myndast.
Gentilini Fabio, Turba Maria Elena, Giancola Fiorella, Chiocchetti Roberto, Bernardini Chiara, Dajbychova Markéta, Jagannathan Vidhya, Drögemüller Michaela, Drögemüller Cord. A large deletion in the GP9 gene in Cocker Spaniel dogs with Bernard-Soulier syndrome. PLoS One. 2019 Sep 4;14(9):e0220625. doi: 10.1371/journal.pone.0220625. eCollection 2019.
Þitt næði, þitt val
Við notum nauðsynlegar vafrakökur til að keyra vefsíðuna. Valfrjálsar vafrakökur (svo sem innbyggðar efnisveitur) eru sjálfgefnar óvirkar og aðeins virkar ef þú samþykkir. Þú getur breytt vali þínu hvenær sem er með því að nota „Cookies“ hnappinn.
Nauðsynlegt fyrir kjarnaeiginleika og öryggi. Alltaf virkt.
Bætir eiginleika eins og vistun vals eða innfellingar án auglýsinga.
Hjálpar okkur að skilja síðunotkun. Sjálfgefið óvirkt.
Auglýsingar/rakningar á vefsvæðum (sum vídeó/kortum innfelld). Sjálfgefið óvirkt.